ZHENGBANG TECHNOLOGY(SZ:002157)2022-12-08 08:20Group 1: Current Operations - In June 2014, the company had a total output of approximately 159,000 pigs, including 72,000 fat pigs, 70,000 piglets, and 17,000 breeding pigs [1] - The company plans to gradually increase pig output over the next three years, depending on the domestic market conditions [1] - The output structure is projected to consist of approximately 10% breeding pigs, 40% piglets, and 50% fat pigs [2] Group 2: Cost Structure and Management - The company's costs are slightly higher than the industry average due to several factors, including the recent establishment of new pig farms and the high depreciation and labor costs associated with them [2] - The company has implemented measures to reduce costs, including organizational restructuring to streamline management and eliminate 10% of ineffective personnel [3] - Production strategies for 2014 focus on cost reduction, improving capacity utilization, and enhancing breeding techniques [3] Group 3: Future Strategic Direction - The overall strategy for 2014 is to build an integrated industry chain, with a gradual slowdown in pig farming growth and a focus on stabilizing existing operations [3] - The feed business is expected to grow by 15% in 2014, with an emphasis on a light asset model and increasing the proportion of pig feed sales to over 50% [3] - The company is actively developing relationships with village-level distributors and medium to large-scale farms for feed sales [3] Group 4: Vaccine Usage - The company currently uses various vaccines from different suppliers, including: - Foot-and-mouth disease: Zhongnong Weite - Blue ear disease: Tiankang Biology, Huawite - Swine fever: Guangdong Yongshun - Pseudorabies: Boehringer [4]